Key result
Atrial fibrillation ablation was associated with a 30-day mortality rate of 0.05% (15 of 30,197 patients) in a nationwide Netherlands registry.
Observational (n=30,197)
Yes
Atrial fibrillation ablation demonstrates a very low 30-day mortality rate (0.05%) in a large, real-world national registry.
Supports AF ablation safety in large real-world cohorts; extends observational data but leaves open need for randomized confirmation.
This study presents the 30-day mortality of patients who underwent atrial fibrillation (AF) ablation between 2013 - 2020 and were registered in the Netherlands Heart Registration. In total, 30,197/30,238 (99.9%) patients were analyzed. Fifteen (0.05%) died within 30 days. Nine deaths were considered procedurally related, four were considered non-procedural related, and in two patients the cause of death was unknown.
No takes yet. Share an insight, caveat, or question.
Mol et al. (2022) conducted an observational in Atrial fibrillation (n=30,197). Atrial fibrillation ablation was evaluated on 30-day mortality. Atrial fibrillation ablation was associated with a 30-day mortality rate of 0.05% (15 of 30,197 patients) in a nationwide Netherlands registry.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: